AVTX
Avalo Therapeutics Inc
NASDAQ: AVTX · HEALTHCARE · BIOTECHNOLOGY
$19.94
-3.75% today
Updated 2026-06-05
Market cap
$733.82M
P/E ratio
—
P/S ratio
12,437.55x
EPS (TTM)
$-5.57
Dividend yield
—
52W range
$4 – $24
Volume
1.7M
Avalo Therapeutics Inc (AVTX) Insider transactions
Net insider activity
Net buying (1,107,051 shares)
Buy transactions
44
Sell transactions
56
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-02 | TRUEX, SAMANTHA | Director | Buy | 20,100 | — | — |
| 2026-06-02 | LIND, KEVIN ROBERT | Director | Buy | 20,100 | — | — |
| 2026-06-02 | KAPLAN, GILLA | Director | Buy | 20,100 | — | — |
| 2026-06-02 | KANTOFF, AARON | Director | Buy | 20,100 | — | — |
| 2026-06-02 | JAIN, RITA | Director | Buy | 20,100 | — | — |
| 2026-06-02 | HEFFERNAN, MICHAEL THOMAS | Director | Buy | 29,500 | — | — |
| 2026-05-28 | DOYLE, MITTIE | Chief Medical Officer | Sale | 679 | — | — |
| 2026-05-28 | DOYLE, MITTIE | Chief Medical Officer | Buy | 679 | $8.04 | $5459.16 |
| 2026-05-21 | VARKI, PAUL | Chief Legal Officer | Buy | 24,300 | — | — |
| 2026-05-21 | SULLIVAN, CHRISTOPHER RYAN | Chief Financial Officer | Buy | 39,900 | — | — |
| 2026-05-21 | RILEY, JENNIFER | Chief Strategy Officer | Buy | 34,200 | — | — |
| 2026-05-21 | NEIL, GARRY ARTHUR | Director, Chief Executive Officer | Buy | 100,200 | — | — |
| 2026-05-21 | DOYLE, MITTIE | Chief Medical Officer | Buy | 43,500 | — | — |
| 2026-05-15 | DOYLE, MITTIE | Chief Medical Officer | Sale | 3,000 | — | — |
| 2026-05-15 | DOYLE, MITTIE | Chief Medical Officer | Sale | 3,000 | $18.76 | $56280.00 |
| 2026-05-07 | SULLIVAN, CHRISTOPHER RYAN | Chief Financial Officer | Sale | 18,606 | — | — |
| 2026-05-07 | SULLIVAN, CHRISTOPHER RYAN | Chief Financial Officer | Sale | 18,606 | $24.12 | $448817.65 |
| 2026-05-06 | VARKI, PAUL | Chief Legal Officer | Sale | 62,500 | — | — |
| 2026-05-06 | VARKI, PAUL | Chief Legal Officer | Sale | 12,563 | — | — |
| 2026-05-06 | VARKI, PAUL | Chief Legal Officer | Buy | 62,500 | $13.43 | $839375.00 |
| 2026-05-06 | VARKI, PAUL | Chief Legal Officer | Sale | 37,375 | $18.91 | $706836.00 |
| 2026-05-06 | VARKI, PAUL | Chief Legal Officer | Sale | 22,839 | $21.22 | $484540.80 |
| 2026-05-06 | VARKI, PAUL | Chief Legal Officer | Buy | 12,563 | $8.04 | $101006.52 |
| 2026-05-06 | VARKI, PAUL | Chief Legal Officer | Sale | 9,253 | $22.70 | $210029.22 |
| 2026-05-06 | VARKI, PAUL | Chief Legal Officer | Sale | 5,196 | $19.78 | $102783.12 |
| 2026-05-06 | VARKI, PAUL | Chief Legal Officer | Sale | 400 | $23.71 | $9484.00 |
| 2026-05-06 | SULLIVAN, CHRISTOPHER RYAN | Chief Financial Officer | Sale | 47,000 | — | — |
| 2026-05-06 | SULLIVAN, CHRISTOPHER RYAN | Chief Financial Officer | Buy | 47,000 | $8.04 | $377880.00 |
| 2026-05-06 | SULLIVAN, CHRISTOPHER RYAN | Chief Financial Officer | Sale | 13,834 | $18.55 | $256655.28 |
| 2026-05-06 | SULLIVAN, CHRISTOPHER RYAN | Chief Financial Officer | Sale | 12,347 | $19.28 | $238093.37 |
| 2026-05-06 | SULLIVAN, CHRISTOPHER RYAN | Chief Financial Officer | Sale | 9,219 | $21.37 | $197008.19 |
| 2026-05-06 | SULLIVAN, CHRISTOPHER RYAN | Chief Financial Officer | Sale | 8,900 | $22.57 | $200913.05 |
| 2026-05-06 | SULLIVAN, CHRISTOPHER RYAN | Chief Financial Officer | Sale | 2,700 | $20.76 | $56052.00 |
| 2026-05-06 | DOYLE, MITTIE | Chief Medical Officer | Sale | 77,905 | — | — |
| 2026-05-06 | DOYLE, MITTIE | Chief Medical Officer | Sale | 28,650 | — | — |
| 2026-05-06 | DOYLE, MITTIE | Chief Medical Officer | Buy | 77,905 | $12.65 | $985498.25 |
| 2026-05-06 | DOYLE, MITTIE | Chief Medical Officer | Sale | 44,944 | $21.20 | $952668.98 |
| 2026-05-06 | DOYLE, MITTIE | Chief Medical Officer | Buy | 28,650 | $8.04 | $230346.00 |
| 2026-05-06 | DOYLE, MITTIE | Chief Medical Officer | Sale | 27,538 | $18.03 | $496405.50 |
| 2026-05-06 | DOYLE, MITTIE | Chief Medical Officer | Sale | 19,015 | $22.41 | $426050.09 |
| 2026-05-06 | DOYLE, MITTIE | Chief Medical Officer | Sale | 10,058 | $22.88 | $230127.04 |
| 2026-05-06 | DOYLE, MITTIE | Chief Medical Officer | Sale | 5,000 | $19.65 | $98251.00 |
| 2026-05-06 | CHAN, MITCHELL | Director | Sale | 3,167 | $22.88 | $72460.96 |
| 2026-05-05 | DOYLE, MITTIE | Chief Medical Officer | Sale | 1,000 | — | — |
| 2026-05-05 | DOYLE, MITTIE | Chief Medical Officer | Sale | 679 | — | — |
| 2026-05-05 | DOYLE, MITTIE | Chief Medical Officer | Sale | 1,679 | $16.00 | $26864.00 |
| 2026-05-05 | DOYLE, MITTIE | Chief Medical Officer | Buy | 1,000 | $12.65 | $12650.00 |
| 2026-05-05 | DOYLE, MITTIE | Chief Medical Officer | Buy | 679 | $8.04 | $5459.16 |
| 2026-04-30 | SULLIVAN, CHRISTOPHER RYAN | Chief Financial Officer | Sale | 8,457 | $13.23 | $111853.13 |
| 2026-04-29 | SULLIVAN, CHRISTOPHER RYAN | Chief Financial Officer | Sale | 8,458 | $13.09 | $110736.36 |
| 2026-04-06 | DOYLE, MITTIE | Chief Medical Officer | Sale | 3,970 | — | — |
| 2026-04-06 | DOYLE, MITTIE | Chief Medical Officer | Buy | 3,970 | $12.65 | $50220.50 |
| 2026-04-02 | SULLIVAN, CHRISTOPHER RYAN | Chief Financial Officer | Sale | 6,200 | $17.02 | $105553.14 |
| 2026-04-02 | SULLIVAN, CHRISTOPHER RYAN | Chief Financial Officer | Sale | 1,780 | $17.57 | $31269.97 |
| 2026-04-01 | SULLIVAN, CHRISTOPHER RYAN | Chief Financial Officer | Sale | 7,479 | $16.83 | $125840.91 |
| 2026-04-01 | SULLIVAN, CHRISTOPHER RYAN | Chief Financial Officer | Sale | 500 | $15.86 | $7929.00 |
| 2026-04-01 | DOYLE, MITTIE | Chief Medical Officer | Sale | 679 | — | — |
| 2026-04-01 | DOYLE, MITTIE | Chief Medical Officer | Sale | 679 | $16.00 | $10864.00 |
| 2026-03-31 | LIND, KEVIN ROBERT | Director | Buy | 1,370 | $12.13 | $16618.10 |
| 2026-03-31 | JAIN, RITA | Director | Buy | 1,339 | $12.13 | $16242.07 |
| 2026-03-28 | TRUEX, SAMANTHA | Director | Sale | 3,166 | — | — |
| 2026-03-28 | TRUEX, SAMANTHA | Director | Buy | 3,166 | — | — |
| 2026-03-28 | SULLIVAN, CHRISTOPHER RYAN | Chief Financial Officer | Sale | 24,200 | — | — |
| 2026-03-28 | SULLIVAN, CHRISTOPHER RYAN | Chief Financial Officer | Buy | 24,200 | — | — |
| 2026-03-28 | SULLIVAN, CHRISTOPHER RYAN | Chief Financial Officer | Sale | 8,241 | $13.89 | $114467.49 |
| 2026-03-28 | NEIL, GARRY ARTHUR | Director, Chief Executive Officer | Sale | 64,866 | — | — |
| 2026-03-28 | NEIL, GARRY ARTHUR | Director, Chief Executive Officer | Buy | 64,866 | — | — |
| 2026-03-28 | NEIL, GARRY ARTHUR | Director, Chief Executive Officer | Sale | 21,892 | $13.89 | $304079.88 |
| 2026-03-28 | KAPLAN, GILLA | Director | Sale | 3,166 | — | — |
| 2026-03-28 | KAPLAN, GILLA | Director | Buy | 3,166 | — | — |
| 2026-03-28 | KANTOFF, AARON | Director | Sale | 3,166 | — | — |
| 2026-03-28 | KANTOFF, AARON | Director | Buy | 3,166 | — | — |
| 2026-03-28 | GOLDMAN, JONATHAN | Director | Sale | 3,166 | — | — |
| 2026-03-28 | GOLDMAN, JONATHAN | Director | Buy | 3,166 | — | — |
| 2026-03-28 | CHAN, MITCHELL | Director | Sale | 3,166 | — | — |
| 2026-03-28 | CHAN, MITCHELL | Director | Buy | 3,166 | — | — |
| 2026-03-16 | DOYLE, MITTIE | Chief Medical Officer | Sale | 19,500 | — | — |
| 2026-03-16 | DOYLE, MITTIE | Chief Medical Officer | Sale | 5,992 | — | — |
| 2026-03-16 | DOYLE, MITTIE | Chief Medical Officer | Sale | 25,492 | $16.15 | $411606.58 |
| 2026-03-16 | DOYLE, MITTIE | Chief Medical Officer | Buy | 19,500 | $12.65 | $246675.00 |
| 2026-03-16 | DOYLE, MITTIE | Chief Medical Officer | Buy | 5,992 | $8.04 | $48175.68 |
| 2026-02-26 | VARKI, PAUL | Chief Legal Officer | Buy | 80,000 | — | — |
| 2026-02-26 | SULLIVAN, CHRISTOPHER RYAN | Chief Financial Officer | Buy | 105,000 | — | — |
| 2026-02-26 | RILEY, JENNIFER | Chief Strategy Officer | Buy | 95,000 | — | — |
| 2026-02-26 | NEIL, GARRY ARTHUR | Director, Chief Executive Officer | Buy | 286,000 | — | — |
| 2026-02-26 | DOYLE, MITTIE | Chief Medical Officer | Buy | 105,000 | — | — |
| 2026-02-26 | BOYD, TAYLOR | Chief Business Officer | Buy | 95,000 | — | — |
| 2025-12-31 | LIND, KEVIN ROBERT | Director | Buy | 848 | $14.74 | $12499.52 |
| 2025-12-31 | JAIN, RITA | Director | Buy | 1,043 | $14.74 | $15373.82 |
| 2025-12-10 | VARKI, PAUL | Chief Legal Officer | Sale | 1,016 | $4.10 | $4165.60 |
| 2025-12-10 | SULLIVAN, CHRISTOPHER RYAN | Chief Financial Officer | Sale | 155 | $4.10 | $635.50 |
| 2025-12-10 | RILEY, JENNIFER | Chief Strategy Officer | Sale | 637 | $4.10 | $2611.70 |
| 2025-12-10 | DOYLE, MITTIE | Chief Medical Officer | Sale | 1,013 | $4.10 | $4153.30 |
| 2025-11-14 | GOLDMAN, JONATHAN | Director | Sale | 8,200 | — | — |
| 2025-11-14 | GOLDMAN, JONATHAN | Director | Buy | 8,200 | $9.88 | $81016.00 |
| 2025-11-14 | GOLDMAN, JONATHAN | Director | Sale | 3,167 | $14.30 | $45288.10 |
| 2025-10-01 | LIND, KEVIN ROBERT | Director | Buy | 40,200 | — | — |
| 2025-10-01 | BOYD, TAYLOR | Chief Business Officer | Buy | 275,000 | — | — |
| 2025-09-30 | JAIN, RITA | Director | Buy | 1,572 | — | — |
| 2025-06-17 | TRUEX, SAMANTHA | Director | Buy | 20,100 | — | — |
Frequently asked questions
Are AVTX insiders buying or selling?
Over the transactions on record, AVTX insiders have been net sellers, with about $6.66M in stock sold across 56 sales, against 16 open-market purchases.
Does insider selling at AVTX mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which AVTX insiders are selling the most?
Recent selling is concentrated in a few names. DOYLE, MITTIE accounts for the largest share on record, with about $2.71M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.